http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022200426-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d33e45e5cbd64b8b893bd62ee22a85b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c979a0cca9409172f11f474dabd9f2b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42f352cc5bd193c17ffff15bf60e16f7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-38
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-38
filingDate 2022-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_851ad2f9eaa6e631417e676827a2bd0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d58165a2026837815f8d08728d04269
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d50e1a0ec3064bbdd3852ab5c76b517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6f7ea8a977b07eedd5fa8b1e67a29d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94fee4fb1c2a963260a285689b31ef75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a68dd51129475ca3ab57d431d6093d2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70a93525ee366b41b5f04e54438aefba
publicationDate 2022-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022200426-A1
titleOfInvention Preparation method of quinoline derivative compounds
abstract The present invention relates to a method for preparing a compound of formula (I) comprising the following steps: (i) reacting a compound of formula (II) with a compound of formula (III), to form the hydrochloride salt of the compound of formula (I), wherein the molar ratio of the compound of formula (II) vs. the compound of formula (III) is from 1.00:0.80 to 1.00:1.20, and no metal catalyst is present, and (ii) recovering the compound of formula (I) in the form of a free base through addition of a base. The present invention also relates to a powder obtained by said method and a powder comprising a compound of formula (I) which is characterized by a particle size distribution with specific D50, D90 and/or D10 values, and a pharmaceutical composition comprising said powders and at least one pharmaceutically acceptable excipient.
priorityDate 2021-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017158201-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010143169-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2465502-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID534918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5150145
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID101886162
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85702142
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100127870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2777991
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49846599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID600848
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53411294
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID340333809
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85702122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399440
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID83932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID676553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167174171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226448267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID477268326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227802191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226448266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID477268287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167174199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227889187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID477268165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227117111
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID244666
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2782639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167174138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6026720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227084653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID225674
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406035455
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226496777
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID333721593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312044457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID477268355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID333721587
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100036995
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7240
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70451296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428088
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226725458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228838181
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID292101

Total number of triples: 83.